[The beta 2-pseudoselectivity of ISA (intrinsic sympathomimetic action)--consequences for differential therapy with beta-blockers with and without ISA?].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D006321:Heart / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D009206:Myocardium / Q000378:metabolism; D011943:Receptors, Adrenergic, beta / Q000187:drug effects* / Q000378:metabolism; D013566:Sympathomimetics
D000319:Adrenergic beta-Antagonists; D011943:Receptors, Adrenergic, beta; D013566:Sympathomimetics
"Beta 2-Pseudoselektivität" der ISA--Konsequenzen für die Differentialtherapie mit Betablockern mit und ohne ISA?